Allmed Medical Products Co., Ltd.

Allmed Medical Products Co., Ltd. is a leading global provider of medical dressings and infection protection solutions, founded in Hong Kong in 1997. The company was listed on the Shenzhen Stock Exchange in March 2019 and is recognized as the first A-share listed enterprise in Zhijiang. Allmed's products are distributed to nearly 70 countries and regions across six continents, and it has consistently topped the export list of China's medical dressing industry since 2008. The company's core business encompasses both professional medical and consumer medical fields. Its professional medical products include medical wound care, surgical consumables, and infection protection, catering to clinical customers. In the consumer sector, Allmed offers home wound care and personal cleaning products, distributed through chain pharmacies and e-commerce channels. With six production bases equipped with advanced manufacturing capabilities, Allmed integrates the entire production process, from raw materials to final products, ensuring high quality and efficiency. The company emphasizes technological innovation, holding nearly 500 national patents, and is recognized for its comprehensive industrial chain and intelligent manufacturing processes.

(I) Advanced manufacturing advantages 1.Comprehensive Industrial Chain and Advanced Equipment Our company stands as one of the select few in the industry, boasting a comprehensive industrial chain and advanced automation capabilities. Over two decades of development, we have amassed substantial industry and production expertise. Through relentless innovation and strategic integration, we have established a systematic production line that aligns with industry-specific characteristics and rivals international standards, encompassing the entire spectrum of production from raw materials and semi-finished goods to deep processing, packaging, sterilization, and testing. We have adopted state-of-the-art production equipment from abroad and concurrently intensified our efforts in the independent development of specialized machinery, securing a portfolio of patents. Our ongoing equipment and process upgrades have bolstered the automation and intelligence across each link of our industrial chain, enhancing the synergy of our integrated production strategy. This comprehensive approach allows us to sustain our competitive edge by ensuring product quality, minimizing production costs, and elevating the level of automation. 2.Scale Production Advantage Our company's dressings are primarily targeted at the European and American markets, where the dressings industry is highly competitive and concentrated. To maintain a competitive price-performance ratio and secure a market foothold, large-scale production capacity is imperative. The diverse needs of downstream customers in terms of product quantity, variety, models, and appearance necessitate a certain level of production scale to ensure timely supply and meet the demands for diversity. Scale production is a pivotal foundation for securing a competitive advantage in the market. After years of development, our company has cultivated a pronounced scale production advantage. As a leading producer and exporter in China's medical dressings industry, we operate multiple production bases equipped with cutting-edge equipment, achieving a high degree of large-scale production. This significant scale advantage has substantially increased our production efficiency and effectively reduced costs. It also ensures the consistency and stability of product quality, meets the timeliness of batch deliveries, and addresses the diversity of procurement needs, thereby enhancing our overall competitiveness and market share. 3.Automation, Informationization, and Intelligent Manufacturing Advantages Our company is among the select few globally with capabilities in high automation, informationization, and intelligent manufacturing. We have evolved from leveraging production management advantages to scaling up production, and now to the forefront of automation, intelligentization, and informationization in manufacturing. By elevating the integration of technology, we have raised the benchmark for maintaining our manufacturing advantages to a new level of technological convergence. (III) Technological Innovation Advantage The company's business strategy is based on the principle of technological innovation, which it regards as the primary driver of growth. It makes a sustained commitment to research and development (R&D), continuously optimising processes, innovating production equipment and technology, and attracting and nurturing talented individuals with innovative skills. These efforts have resulted in the establishment of a comprehensive and effective R&D system, which has reinforced the company's competitive advantage within its industry. As a high-tech enterprise with a focus on medical dressings, the company has obtained the requisite invention patent authorization, accumulated a substantial corpus of technical achievements, and maintained its leading position in the medical dressing industry. In addition to sustaining investment in product innovation and enhancement, equipment modernization, and renovation, the company has augmented its investment in automation, informationization, and intelligent management. This has resulted in the acquisition of several software copyrights, including the "Allmed Medical WMS Management System," the Allmed Barcode Management System," the Allmed & Mather WMS Management System," the Allmed Barcode Management System," the Allmed ETO Sterilization Process Visualization Management Software," and numerous others. (IV) Market Resource Advantage The company adheres to the core values of "integrity, focus, professionalism," and continues to provide customers with high-quality products and services. Medical dressing products are mainly used for export and are sold to nearly 40 countries or regions on six continents. The majority of sales are to the United States, Canada, Germany, Japan, and other countries and regions. Overseas customers are primarily internationally renowned brands, and the company has established long-term and stable cooperative relationships, forming an outstanding customer resource advantage. The company's overseas customers are primarily international brands with which it has established long-term and stable cooperative relationships, thereby acquiring a significant competitive advantage in terms of customer resources. In recent years, the company has witnessed a continued increase in its market share in certain key markets. The company has been engaged in the medical and healthcare business for an extended period, addressing customer requirements pertaining to product quality, production capacity assurance, delivery time, customer service, and other aspects. It has established a robust customer service infrastructure and cultivated stable customer relationships through the provision of high-quality pre- and post-sales support. Presently, the company's global customer base encompasses Medline, Dukal, Hartmann, Lohmann & Rauscher, Medicom, Johnson & Johnson, and other globally renowned enterprises. Through long-term strategic collaboration with these esteemed partners, the company has witnessed a symbiotic growth trajectory, with its products gaining recognition and customer loyalty. This has enabled the company to achieve sustainable development and maintain its core competitiveness.